Filtered By:
Condition: Diabetes Type 2

This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 3594 results found since Jan 2013.

Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study
Conclusion T2DM and HTN were strongly associated with combined VE and stroke risk; however, the HTN-only group had a higher combined VE and stroke risk than the T2DM-only group.
Source: BMJ Open - November 29, 2021 Category: General Medicine Authors: Liu, Y., Li, J., Dou, Y., Ma, H. Tags: Open access, Diabetes and Endocrinology Source Type: research

Low-Density Lipoprotein Cholesterol Level After a Stroke
Randomized clinical trials (RCTs) of statins as the primary prevention for patients with a high serum low-density lipoprotein cholesterol (LDL-C) level and as the secondary prevention after an acute coronary event have shown that lowering serum LDL-C levels reduces the risks of myocardial infarction, stroke, and vascular death. These trials included stroke as a secondary end point but not as an entry criterion. The benefit of LDL-C lowering to reduce the risk of ischemic strokes in primary prevention trials and for patients with coronary heart disease is not necessarily seen among patients who have had a stroke. The Stroke...
Source: JAMA Neurology - February 21, 2022 Category: Neurology Source Type: research

033 GLP-1RAs reduce stroke incidence in patients with type 2 diabetes mellitus: a meta-analysis
Conclusions This data supports the value of GLP-1RAs in reducing stroke incidence in patients with T2DM. There is potential value in prospective, randomised controlled trials adequately powered to establish the value of GLP-1RAs in stroke prevention in T2DM patients. mark.maskery@doctors.org.uk|ABN Bursary
Source: Journal of Neurology, Neurosurgery and Psychiatry - May 27, 2022 Category: Neurosurgery Authors: Maskery, M., Wall, J., Holscher, C., Jones, S., Price, C., Strain, D., Watkins, C., Werring, D., Emsley, H. Tags: Live Poster, 6 May SIG4: Movement Disorders Source Type: research

Association between diabetes mellitus and post ‐stroke cognitive impairment
PSD and PSCI impose heavy burdens on patients, families, and society. However, cognitive function after stroke is dynamic and dysfunction is often overlooked. Impaired fasting glucose, prediabetes, type 2 DM, hypoglycemia, and glycemic variability may lead to cognitive dysfunction after stroke via various mechanisms and pathways. There is emerging evidence regarding the association between different DM medications and cognitive functions. However, their relationship with the PSCI/PSD warrants further investigation. AbstractStroke survivors suffer from various physical, emotional, and cognitive impairments. These changes ar...
Source: Journal of Diabetes Investigation - October 1, 2022 Category: Endocrinology Authors: Kang ‐Po Lee, Jung‐Sheng Chen, Chih‐Yuan Wang Tags: Mini Review Source Type: research

Development and validation of risk prediction models for stroke and mortality among patients with type 2 diabetes in northern China
ConclusionIn this study, we developed and validated first-ever risk prediction models for stroke and death from stroke in patients with T2DM, with good discrimination and calibration observed in all models. Based on lifestyle, demographic characteristics, and laboratory examination, these models could provide multidimensional management and individualized risk assessment. However, the models developed here may only be applicable to Han Chinese.
Source: Journal of Endocrinological Investigation - January 20, 2023 Category: Endocrinology Source Type: research

SGLT2 inhibitors: Effect on myocardial infarction and stroke in type 2 diabetes
J Clin Endocrinol Metab. 2023 Feb 28:dgad113. doi: 10.1210/clinem/dgad113. Online ahead of print.ABSTRACTBACKGROUND: SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors) have recently been recommended as preferred agents for management of hyperglycemia in type 2 diabetes, primarily based on their ability to reduce a composite of major cardiovascular adverse events (3P MACE), predominantly by reducing cardiovascular death. However reduction of the individual components, myocardial infarction (MI) or stroke (fatal and non-fatal) events have not been well explored.METHODS: In this meta-analysis, we included data avail...
Source: The Journal of Clinical Endocrinology and Metabolism - March 1, 2023 Category: Endocrinology Authors: Pradip Mukhopadhyay Debmalya Sanyal Purushottam Chatterjee Kaushik Pandit Sujoy Ghosh Source Type: research

Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus
AbstractPurpose of ReviewThe aim of this study is to investigate the protective effects of different statin classes, intensity, and cumulative dose-dependent against primary ischemic stroke in patients with T2DM.Recent FindingsThe Cox hazards model was used to evaluate statin use on primary ischemic stroke. Case group: T2DM patients who received statins; control group: T2DM patients who received no statins during the follow-up. Adjusted hazard ratio (aHR) for primary ischemic stroke was 0.45 (95% CI: 0.44 to 0.46). Cox regression analysis showed significant reductions in primary ischemic stroke incidence in users of differ...
Source: Current Atherosclerosis Reports - July 29, 2023 Category: Cardiology Source Type: research

Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental stroke
Abstract Metformin is currently the first‐line treatment drug for type 2 diabetes. Metformin is a well‐known activator of AMP‐activated protein kinase (AMPK). In experimental studies, metformin has been shown to exert direct vascular effects by increasing vascular endothelial growth factor expression and improving microvascular density. As stroke is the leading cause of long‐term disability and angiogenesis is implicated as an important mechanism in functional recovery, we hypothesized that chronic metformin treatment would improve post‐stroke functional recovery by enhancing functional microvascular density. For...
Source: European Journal of Neuroscience - March 1, 2014 Category: Neuroscience Authors: Venugopal R. Venna, Jun Li, Matthew D. Hammond, Nickolas S. Mancini, Louise D. McCullough Tags: Research Report Source Type: research

Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.
In conclusion, hyperglycemia may activate platelets through miR-144 and miR-223 to downregulate IRS-1 and upregulate P2Y12 expression in the platelets of T2DM patients through an IRS-1-PI3K-Akt signaling. Low platelet and plasma miR-223 expression in addition to high platelet and plasma miR-144 expression are risk factors for ischemic stroke in T2DM patients. PMID: 26175178 [PubMed - as supplied by publisher]
Source: Cardiovascular Toxicology - July 15, 2015 Category: Cardiology Authors: Yang S, Zhao J, Chen Y, Lei M Tags: Cardiovasc Toxicol Source Type: research

Study: 3D MRI reveals early stroke risk in diabetics
A new study suggests that diabetes patients may be at a higher risk for stroke due to harboring advanced vascular disease, and that arterial imaging with 3D MRI could help determine stroke risk in diabetes patients. Data from the study is slated to be presented at the Radiological Society of North America’s annual meeting next week. “A recent analysis of multiple studies has shown that people with carotid artery narrowing and IPH have a 5- to 6-times higher risk of stroke in the near future compared to people without,” study author Dr. Tishan Maraj of Sunnybrook Research Institute said in prepared remark...
Source: Mass Device - November 24, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Diabetes Vascular Radiological Society of North America Source Type: news

Lower Extremity Peripheral Arterial Disease Is an Independent Predictor of Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus in China.
In conclusion, lower extremity PAD increased coronary heart disease and stroke risks in T2DM. PMID: 28607554 [PubMed - in process]
Source: International Journal of Endocrinology - June 14, 2017 Category: Endocrinology Tags: Int J Endocrinol Source Type: research